Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for vascular function and cardiovascular risk factors in youth with type 1 diabetes
IRCT20230930059564N1Phase 4Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Metformin with Placebo (2 arms). Primary endpoint: Flow-mediated dilatation. Started Dec 2023; status: completed.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT20230930059564N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230930059564N1.